Molecular Imaging Market, By Product Type (Devices (Molecular Ultrasound Imaging, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Nuclear Magnetic Resonance (NMR) Spectrometer, Hybrid Products ( Positron Emission Tomography - Computed Tomography (PET-CT), Positron Emission Tomography- Magnetic Resonance (PET-MR), Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT), Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)), Software Platforms (On Premises Solutions, Cloud Based Solutions)), By Application (Cardiovascular, Neurology, Oncology, Respiratory, Gastrointestinal, Others Application), By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Molecular Imaging Market, By Product Type (Devices (Molecular Ultrasound Imaging, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Nuclear Magnetic Resonance (NMR) Spectrometer, Hybrid Products ( Positron Emission Tomography - Computed Tomography (PET-CT), Positron Emission Tomography- Magnetic Resonance (PET-MR), Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT), Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)), Software Platforms (On Premises Solutions, Cloud Based Solutions)), By Application (Cardiovascular, Neurology, Oncology, Respiratory, Gastrointestinal, Others Application), By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Molecular imaging (MI) is a rapidly expanding biomedical research discipline that allows for the imaging, characterization, and quantification of biologic processes occurring at the cellular and subcellular levels in intact living organisms, including patients. MI pictures represent disease-related cellular and molecular pathways and mechanisms in the setting of a living patient. MI facilitates the study of biologic processes in their physiologically authentic milieu, overcoming the constraints and limits of in vitro or ex vivo biopsy and cell culture laboratory procedures. It also includes 'multiple' image-capture techniques as well as knowledge domains from cell and molecular biology, chemistry, pharmacology, medical physics, biomathematics, and bioinformatics. Modern clinical scientific researchers employ MI to investigate how molecular defects observed in cells accumulate to become the basis of disease.
Market Dynamics
The key players in the industry are focusing on the research and development for advanced techniques in the market. Thus, the introduction of such advanced products in the market is expected to drive growth of the global molecular imaging market over the forecast period. For instance, on June 20, 2023, Blue Earth Therapeutics, a Bracco company and leader in the development of innovative next-generation therapeutic radiopharmaceuticals, delivered upcoming corporate and employee presentations at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting scheduled for March 24, 2023 in Chicago, Illinois. The conference will feature presentations on clinical and preclinical research studies on therapeutic applications of radiohybrid prostate-specific membrane antigen (rhPSMA) technology. This includes early clinical experience and preclinical evaluation of 177Lu-rhPSMA-10.1, which is currently being investigated by Blue Earth Therapeutics as a potential PSMA-targeted therapeutic radiopharmaceutical candidate for the treatment of prostate cancer.
Key features of the study:
This report provides an in-depth analysis of the global molecular imaging market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global molecular imaging market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include GE Healthcare, Bruker Corporation, Fujifilm Holdings Corp., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, United Imaging Healthcare Co., Ltd., Mediso Kft., Positron Corporation, Esaote SpA, Carestream Health, Mirada Medical Limited and Hermes Medical Solutions
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global molecular imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular imaging market
Global Molecular Imaging Market Detailed Segmentation:
By Product Type:
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)